Skip to content
10-Q

Quarterly Report

NEOS THERAPEUTICS, INC.

0001558370-20-010196

← back to feed
Filed
Aug 10, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Aug 3, 2020 49.76M sh
Capex Q2 2020 · Jun 30, 2020 $262K
Capex Q2 2020 · Jun 30, 2019 $365K
Operating Cash Flow Q2 2020 · Jun 30, 2020 −$5.53M
Operating Cash Flow Q2 2020 · Jun 30, 2019 −$7.86M
Cash And Equivalents Q2 2020 · Jun 30, 2020 $12.68M
Cash And Equivalents Q2 2020 · Dec 31, 2019 $16.83M
Stockholders Equity Q2 2020 · Jun 30, 2020 −$16.17M
Stockholders Equity Q2 2020 · Dec 31, 2019 −$6.13M
Stockholders Equity Q2 2020 · Jun 30, 2019 −$1.61M
Current Liabilities Q2 2020 · Jun 30, 2020 $60.86M
Current Liabilities Q2 2020 · Dec 31, 2019 $63.36M
Current Assets Q2 2020 · Jun 30, 2020 $40.41M
Current Assets Q2 2020 · Dec 31, 2019 $66.56M
Total Assets Q2 2020 · Jun 30, 2020 $62.69M
Total Assets Q2 2020 · Dec 31, 2019 $90.87M
Sga Expense Q2 2020 · Jun 30, 2020 $3.59M
Sga Expense Q2 2020 · Jun 30, 2020 $7.96M
Sga Expense Q2 2020 · Jun 30, 2019 $3.71M
Sga Expense Q2 2020 · Jun 30, 2019 $7.51M
Rd Expense Q2 2020 · Jun 30, 2020 $1.32M
Rd Expense Q2 2020 · Jun 30, 2020 $3.36M
Rd Expense Q2 2020 · Jun 30, 2019 $2.01M
Rd Expense Q2 2020 · Jun 30, 2019 $5.21M
Net Income Q2 2020 · Jun 30, 2020 −$5.51M
Net Income Q2 2020 · Jun 30, 2020 −$13.46M
Net Income Q2 2020 · Dec 31, 2019 −$16.9M
Net Income Q2 2020 · Jun 30, 2019 −$3.76M
Net Income Q2 2020 · Jun 30, 2019 −$11.36M
Net Income Q2 2020 · Dec 31, 2018 −$51.7M
Operating Income Q2 2020 · Jun 30, 2020 −$2.88M
Operating Income Q2 2020 · Jun 30, 2020 −$8.76M
Operating Income Q2 2020 · Jun 30, 2019 −$2.45M
Operating Income Q2 2020 · Jun 30, 2019 −$8.27M
Gross Profit Q2 2020 · Jun 30, 2020 $7.26M
Gross Profit Q2 2020 · Jun 30, 2020 $15.36M
Gross Profit Q2 2020 · Jun 30, 2019 $10.54M
Gross Profit Q2 2020 · Jun 30, 2019 $18.78M
Cost Of Revenue Q2 2020 · Jun 30, 2020 $5.88M
Cost Of Revenue Q2 2020 · Jun 30, 2020 $12.27M
Cost Of Revenue Q2 2020 · Jun 30, 2019 $5.1M
Cost Of Revenue Q2 2020 · Jun 30, 2019 $11.5M
Revenue Q2 2020 · Jun 30, 2020 $13.13M
Revenue Q2 2020 · Jun 30, 2020 $27.63M
Revenue Q2 2020 · Jun 30, 2019 $15.64M
Revenue Q2 2020 · Jun 30, 2019 $30.28M